Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I cannot wait to hear it all...I do love the Idaho gig, seems like a vacation spot to hang with peers but to also "recharge" after a busy speaking season. It seems so tactically arraigned.
Got me, promoting my point of view... "what is factual and not assumed."
That's it.
I don't like those who post wrong info knowing it's wrong. For a long time, I thought NWBO owned Advent, because of this board. So, when I see something so mis-leading, I do my best to correct it.
Antihama, NOT keynote. Only regular speaker.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168560932
LMFAO... I don't care for most posts, but that is funny and well needed.... and true.
Dr. Liau is head of a BIG department... there are so many subjects she is involved in... the speaking subject could be anything, as UCLA's cancer immunotherapy program does more than ALT-DC.
I am Long, but am tired of posts linking Dr. Liau to ONLY NWBO and ONLY TLD, just to to increase the share price to only see it deflated when those fake goalposts are not met.
Yes, kinda some more embellishments by promoters, 'NOT' keynote, just a regulars speaker.
Sweet, 'but' LL session is " Unique Challenges in Emerging Immunotherapies"... so, let's repeat, "challenges"... Don't fall for TLD assumption based on a discussions about challenges of something we are begging for...
I am super hopeful we can glean something new, but it certainly could be combo trial based info, or that outside of our NWBO universe, DC vaccines are not understood or accepted yet, hence Bosch's ASCO's title.
Nice Find...How did you find this one...lol.
Musella Newslette, 4/10/22, DCVAX mentioned.
Musella Newsletter 4/10/22
Advatage to Johnnygogo .... dang... May 2021..
I don't expect PR for MB, due to the history of placeholding. Them announcing and then cancelling would be fodder for more frivolous lawsuits, calling LPOW a liar... etc...
TLD Soon a foregone conclusion.
I am glad to see the ASCO title and subject.
I cannot imagine MB would speak again about dendritic cancer vaccines at this level of an event, unless there was substance.
This group of people are educated, and given the fire for immunology the last 10 years, everyone there is well aware of Dendritic Cells and how masterful they are.... it's the darn harnessing them that is tough. (that is where patents come in to play).
"Industry Expert Theater (IET) sessions are not official presentations of the 2022 ASCO Annual Meeting and are not sponsored, endorsed, or accredited by ASCO."
They are also "educational sessions", yet, no CME.
So, kinda of a downer, but it's a something to drum up journal support for.
Expect stock volatility until we read "Results from P3 trial".
Who is Northwest Biosciences ??? Plot Thickens....
I watched the Senate mistreat Anita Hill when Clarence Thomas perjured his way onto the Supreme Court decades ago. He was a mediocrity then and still is now. Anita told the truth. Every woman her age in the workforce knew it! The Senate was just as rude to almost Justice Jackson. https://t.co/7UL6PTlQds
— Joan Lappin CFA (@joanlappin) April 7, 2022
I expect PR for ASM today...only thin that makes sense.
Only Screenplay will be for episode of "American Greed"...
See, it could be greed for shorts, for longs, for management... Greed is Good.
Kristen Power's Dad's Brain Tumor Walk
Kristen Power's Dad's Brain Tumor Walk
PLEASE DONATE !!!
2022 Grill Reveal 12:30 EST
I can tell you, demand for the new, very expensive models, is very high and customers have no problem opening their wallets; like, it's not even a question.
You are about to get many ultra-long winded responses about SAP and how it has been written about so many times already. I write one sentence to question something, get 1000 word essay back, often, not on the same topic as the question. This goes for a NWBO positive or negative question. Both sides are playing the same game techniques.
I am long, but also have concerns about the crossover.
Sirp, I may not see your response since I put you on 'ignore' a long time ago. Nothing personal.
I agree... Period.
Bio, would 146,000,000 more shares diluting since 1/2020 get it below $1 and not so much sentiment ?
Perhaps a combo of those two factors??
TLD = Totally Living Data
I mean, FDA/MHRA could accept it.... lol.
Can ASCO booth have Long Survivors sitting there ??
That would be great.
Thanks for saving it 😂👍🏻
— 🇩🇰 The Danish Dude 🇩🇰 (@FlemmingBruce) March 22, 2022
I keep my eyes open... I am not going to feel sucker punched by closing my eyes to a third possibility.
Analogy: Does a company increase same-store-sales year to year, or decrease... well, third option, 'same'... so, 3 possibilities exist, regardless of long/short/neutral position.
Retail investors closing their eyes and only hearing 2 narratives is a dream for some money makers.
It can be DCVAX works, but trial bad...
It seems we are always saying Trial Failed, thus DCVAX does not work.
OR
It seems we are always saying Trial Successes, thus DCVAX works...
BUT
Never said is...
Trial failed, but DCVAX Still works....
this is where I fall... I am long and HODL, but that darn Crossover... what a pain... We still don't know why the trial halt... perhaps NWBO did not follow or meet expectations on what was agreed to that allowed resumption?
So, Update Clinicaltrials.gov to verify "Recruitment status was: Active, not recruiting".
That seems to not be a relevant talking point when talking about treating deadly cancer.
There are over 11,000 listings that show "unknow status" for the term "cancer"... https://clinicaltrials.gov/ct2/results?term=cancer&Search=Apply&recrs=m&age_v=&gndr=&type=&rslt=
So, are you going to break your keyboard and have your fingers fly off finding those companies and hold them accountable on a message board ??
Agreed on Dr. Ashkan. I would love to see a study of non-clinical results.
I'm sure Dr. Liau and LPOW/Marnix would have a similar file for compassionate USA treatments.
ASCO "Enhanced" benefits PDF
They don't get much...but I guess for 2 grand more, what else can you expect.
ASCO Exhibit Sales Page
Yes, the are the Anti-Pump.. LOL
But I appreciate their attitude after what they have been through.
I suspect I would be the same.
I think they have learned... looking back at youtube videos 5+ years ago, the hope for TLD very soon...and then hiccups happen... regulatory things change. They are learning...the hard way.
I believe they have surrounded themselves with excellent people and are following the advice they are given on how to proceed.
If they updated website, stock would go crazy.
Some here would Flip out and the Due Dilegence(DD) crowd would be non-stop about it. I mean, we think they are bad now... just imagine...
Problem is, if they did update, and nothing new happens, then non-longs would attack.
So, best course is getting lifeboat up and running.
SEC is an Off-Shore Shell Company. IMHO.
Dr. Bota and Aivita abstract AACR 4/11/22
Aivita is the one who AF and CEO called NWBO a failed trial.
Not sure if this abstract will be noteworthy or not. Hopefully the latter.
Dr Bota AACR Aivita
DCVax-Late... trademark maybe? LOL
YES... that is done with Patents !!
That was the quote I was thinking about.
Thanks RRH
Stein probably fishing for Cofer results.
I have always said Cofer was here for Patent duties, given he was paraphrased as saying 'to protect NWBO assets and technologies'... paraphrasing done by myself... Don't have time to re-look up his actual quote.
Why was Optivo/DCVax-L Trial Withdrawn ?
The recruitment status says "Withdrawn (Final contract negotiations)"
I was not around then, does anyone have knowledge to what happened?
Nivolumab DCVax-L Trial Withdrawn
newman, clearly, Stupp does not feel DCVax is the silver bullet, or he would not be pursuing more, new and novel technologies.
Calling Dr. Stupp adding to his SAB resume "team building" is hilarious. Made me laugh. Thank You for that one.